Current Psychiatry Reports

, 15:419 | Cite as

Medical Consequences of Marijuana Use: A Review of Current Literature

  • Adam J. Gordon
  • James W. Conley
  • Joanne M. Gordon
Substance Use and Related Disorders (JR McKay, Section Editor)
Part of the following topical collections:
  1. Topical Collection on Substance Use and Related Disorders

Abstract

With the advent of legalization of marijuana for medicinal and recreational purposes, and the increase use of marijuana, healthcare providers will be increasingly confronted with marijuana users as patients in clinical environments. While there is vast literature regarding the societal and mental health harms associated with marijuana use, there is a paucity of reviews of the potential consequences of marijuana use on physical health or medical conditions. We examine the recent literature on the physical harms associated with illicit and legal marijuana administration. We surveyed the peer-reviewed medical literature from 1998 to 2013 of studies assessing the association of marijuana use and physical diseases. We conclude that healthcare providers should be cognizant that the existing literature suggests that marijuana use can cause physical harm. However, evidence is needed, and further research should be considered, to prove causal associations of marijuana with many physical health conditions.

Keywords

Marijuana Medical consequences Review Substance use and related disorders Psychiatry 

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. 1.
    Wall MM, Poh E, Cerda M, et al. Adolescent marijuana use from 2002 to 2008: higher in states with medical marijuana laws, cause still unclear. Ann Epidemiol. 2011;21:714–6.PubMedGoogle Scholar
  2. 2.
    Drug Enforcement Administration. Drug Scheduling. Available at http://www.justice.gov/dea/druginfo/ds.shtml. Accessed September 2013.
  3. 3.
    Eidelman WS. Should physicians support the medical use of marijuana? Yes: it can be effective when all else fails. Point West J Med. 2002;176:76.Google Scholar
  4. 4.
    Grinspoon L, Bakalar JB. Marihuana. The forbidden medicine. New Haven: Yale University Press; 1995.Google Scholar
  5. 5.
    Kassirer JP. Federal foolishness and marijuana. N Engl J Med. 1997;336:366–7.PubMedGoogle Scholar
  6. 6.
    Annas GJ. Reefer madness—the federal response to California’s medical-marijuana law. N Engl J Med. 1997;337:435–9.PubMedGoogle Scholar
  7. 7.
    American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington: American Psychiatric Publishing; 2013.Google Scholar
  8. 8.
    United Nations Office on Drugs and Crime. World drug report 2012. New York: United Nations; 2012.Google Scholar
  9. 9.
    Pew Research Center. Majority now supports legalizing marijuana. Washington, DC: People Press; 2013.Google Scholar
  10. 10.
    Johnston LD, O'Malley PM, Bachman JG, Schulenberg JE. Monitoring the future national survey results on drug use: 2012 overview, key findings on adolescent drug use. Ann Arbor: Institute for Social Research, The University of Michigan; 2013.Google Scholar
  11. 11.
    Centers for Disease Control and Prevention (CDC). Youth risk behavior surveillance—United States, 2011. MMWR Morb Mortal Wkly Rep; 2012Google Scholar
  12. 12.
    American Society of Addiction Medicine. White Paper on state-level proposals to legalize marijuana. Available at http://www.asam.org/advocacy/find-a-policy-statement/view-policy-statement/public-policy-statements/2012/07/30/state-level-proposals-to-legalize-marijuana. Accessed September 2013.
  13. 13.
    Budney AJ, Moore BA. Development and consequences of cannabis dependence. J Clin Pharmacol. 2002;42(11 Suppl):28S–33S.PubMedGoogle Scholar
  14. 14.
    Gordon AJ, Gordon JM, Carl K, et al. Physical illness and drugs of abuse: a review of the evidence. Cambridge: Cambridge University Press; 2010.Google Scholar
  15. 15.
    Graham AW, Schultz TK, editors. Principles of addiction medicine. 2nd ed. Chevy Chase: American Society of Addiction Medicine; 1998.Google Scholar
  16. 16.
    Frances RJ, Miller SI, Mack AH, editors. Clinical textbook of addictive disorders. 3rd ed. New York: The Guilford Press; 2005.Google Scholar
  17. 17.
    Brick J, editor. Handbook of the medical consequences of alcohol and drug abuse. Binghamton: The Haworth Press; 2004.Google Scholar
  18. 18.
    Hall W, Degenhardt L. Adverse health effects of non-medical cannabis use. Lancet. 2009;374:1383–91.PubMedGoogle Scholar
  19. 19.
    Lee MJ. Marihuana and tobacco use in pregnancy. Obstet Gynecol Clin North Am. 1998;25:65–83.PubMedGoogle Scholar
  20. 20.
    Kuczkowski KM. Marijuana in pregnancy. Ann Acad Med Singapore. 2004;33:336–9.PubMedGoogle Scholar
  21. 21.
    Sundram S. Cannabis and neurodevelopment: implications for psychiatric disorders. Hum Psychopharmacol. 2006;21:245–54.PubMedGoogle Scholar
  22. 22.
    Behnke M, Eyler FD. The consequences of prenatal substance use for the developing fetus, newborn, and young child. Int J Addict. 1993;28:1341–91.PubMedGoogle Scholar
  23. 23.
    Schempf AH. Illicit drug use and neonatal outcomes: a critical review. Obstet Gynecol Surv. 2007;62:749–57.PubMedGoogle Scholar
  24. 24.
    Day NL, Richardson GA. Prenatal marijuana use: epidemiology, methodologic issues, and infant outcome. Clin Perinatol. 1991;18:77–91.PubMedGoogle Scholar
  25. 25.
    Hall W, Degenhardt L. Cannabis use and psychosis: a review of clinical and epidemiological evidence. Aust N Z J Psychiatry. 2000;34:26–34.PubMedGoogle Scholar
  26. 26.
    Friedman H, Pross S, Klein TW. Addictive drugs and their relationship with infectious diseases. FEMS Immunol Med Microbiol. 2006;47:330–42.PubMedGoogle Scholar
  27. 27.
    Klein TW, Friedman H, Specter S. Marijuana, immunity and infection. J Neuroimmunol. 1998;83:102–15.PubMedGoogle Scholar
  28. 28.
    Munckhof WJ, Konstantinos A, Wamsley M, et al. A cluster of tuberculosis associated with use of a marijuana water pipe. Int J Tuberc Lung Dis. 2003;7:860–5.PubMedGoogle Scholar
  29. 29.
    Oeltmann JE, Oren E, Haddad MB, et al. Tuberculosis outbreak in marijuana users, Seattle, Washington, 2004. Emerg Infect Dis. 2006;12:1156.PubMedGoogle Scholar
  30. 30.
    Krause G, Blackmore C, Wiersma S, et al. Marijuana use and social networks in a community outbreak of meningococcal disease. South Med J. 2001;94:482–5.PubMedGoogle Scholar
  31. 31.
    Finn R, Groves C, Coe M, et al. Cluster of serogroup C meningococcal disease associated with attendance at a party. South Med J. 2001;94:1192–4.PubMedGoogle Scholar
  32. 32.
    Liau A, di Clemente RJ, Wingood GM. Associations between biologically confirmed marijuana use and laboratory-confirmed sexually transmitted diseases among African American adolescent females. Sex Transm Dis. 2002;29:387–90.PubMedGoogle Scholar
  33. 33.
    Darling MR, Arendorf TM, Coldrey NA. Effect of cannabis use on oral candidal carriage. J Oral Pathol Med. 1990;19:319–21.PubMedGoogle Scholar
  34. 34.
    Darling MR, Arendorf TM. Review of the effects of cannabis smoking on oral health. Int Dent J. 1992;42:19–22.PubMedGoogle Scholar
  35. 35.
    Hezode C, Zafrani ES, Roudot-Thoraval F, et al. Daily cannabis use: a novel risk factor of steatosis severity in patients with chronic hepatitis C. Gastroenterology. 2008;134:432–9.PubMedGoogle Scholar
  36. 36.
    Ishida JH, Peters MG, Jin C, et al. Influence of cannabis use on severity of hepatitis C disease. Clin Gastroenterol Hepatol. 2008;6:69–75.PubMedGoogle Scholar
  37. 37.
    Hashibe M, Ford DE, Zhang ZF. Marijuana smoking and head and neck cancer. J Clin Pharmacol. 2002;42(11 Suppl):103S–7S.PubMedGoogle Scholar
  38. 38.
    Hashibe M, Straif K, Tashkin DP, et al. Epidemiologic review of marijuana use and cancer risk. Alcohol. 2005;35:265–75.PubMedGoogle Scholar
  39. 39.
    Mehra R, Moore BA, Crothers K, et al. The association between marijuana smoking and lung cancer: a systematic review. Arch Intern Med. 2006;166:1359–67.PubMedGoogle Scholar
  40. 40.
    Carriot F, Sasco AJ. Cannabis and cancer. Rev Epidemiol Sante Publique. 2000;48:473–83.PubMedGoogle Scholar
  41. 41.
    Zhang ZF, Morgenstern H, Spitz MR, et al. Marijuana use and increased risk of squamous cell carcinoma of the head and neck. Cancer Epidemiol Biomarkers Prev. 1999;8:1071–8.PubMedGoogle Scholar
  42. 42.
    Rosenblatt KA, Daling JR, Chen C, et al. Marijuana use and risk of oral squamous cell carcinoma. Cancer Res. 2004;64:4049–54.PubMedGoogle Scholar
  43. 43.
    Nieder AM, Lipke MC, Madjar S. Transitional cell carcinoma associated with marijuana: case report and review of the literature. Urology. 2006;67:200.PubMedGoogle Scholar
  44. 44.
    Chacko JA, Heiner JG, Siu W, et al. Association between marijuana use and transitional cell carcinoma. Urology. 2006;67:100–4.PubMedGoogle Scholar
  45. 45.
    Daling JR, Doody DR, Sun X, et al. Association of marijuana use and the incidence of testicular germ cell tumors. Cancer. 2009;115:1215–23.PubMedGoogle Scholar
  46. 46.
    Trabert B, Sigurdson AJ, Sweeney AM, et al. Marijuana use and testicular germ cell tumors. Cancer. 2011;117:848–53.PubMedGoogle Scholar
  47. 47.
    Lacson JC, Carroll JD, Tuazon E, et al. Population-based case–control study of recreational drug use and testis cancer risk confirms an association between marijuana use and nonseminoma risk. Cancer. 2012;118:5374–83.PubMedGoogle Scholar
  48. 48.
    Berthiller J, Lee YC, Boffetta P, et al. Marijuana smoking and the risk of head and neck cancer: pooled analysis in the INHANCE consortium. Cancer Epidemiol Biomarkers Prev. 2009;18:1544–51.PubMedGoogle Scholar
  49. 49.
    Aldington S, Harwood M, Cox B, et al. Cannabis use and cancer of the head and neck: case–control study. Otolaryngol Head Neck Surg. 2008;138:374–80.PubMedGoogle Scholar
  50. 50.
    Hashibe M, Morgenstern H, Cui Y, et al. Marijuana use and the risk of lung and upper aerodigestive tract cancers: results of a population-based case–control study. Cancer Epidemiol Biomarkers Prev. 2006;15:1829–34.PubMedGoogle Scholar
  51. 51.
    Voirin N, Berthiller J, Benhaim-Luzon V, et al. Risk of lung cancer and past use of cannabis in Tunisia. J Thorac Oncol. 2006;1:577–9.PubMedGoogle Scholar
  52. 52.
    Aldington S, Harwood M, Cox B, et al. Cannabis use and risk of lung cancer: a case–control study. Eur Respir J. 2008;31:280–6.PubMedGoogle Scholar
  53. 53.
    Taylor III FM. Marijuana as a potential respiratory tract carcinogen: a retrospective analysis of a community hospital population. South Med J. 1988;81:1213–6.PubMedGoogle Scholar
  54. 54.
    Cho CM, Hirsch R, Johnstone S. General and oral health implications of cannabis use. Aust Dent J. 2005;50:70–4.PubMedGoogle Scholar
  55. 55.
    Darling MR, Arendorf TM. Effects of cannabis smoking on oral soft tissues. Community Dent Oral Epidemiol. 1993;21:78–81.PubMedGoogle Scholar
  56. 56.
    Thomson WM, Poulton R, Broadbent JM, et al. Cannabis smoking and periodontal disease among young adults. JAMA. 2008;299:525–31.PubMedGoogle Scholar
  57. 57.•
    Lee MH, Hancox RJ. Effects of smoking cannabis on lung function. Expert Rev Respir Med. 2011;5:537–46. Expert review of marijuana-induced respiratory inflammation and dysfunction..PubMedGoogle Scholar
  58. 58.•
    Hancox RJ, Poulton R, Ely M, et al. Effects of cannabis on lung function: a population-based cohort study. Eur Respir J. 2010;35:42–7. Large longitudinal styudy of marijuana users over 29-year period..PubMedGoogle Scholar
  59. 59.•
    Pletcher MJ, Vittinghoff E, Kalhan R, et al. Association between marijuana exposure and pulmonary function over 20 years. JAMA. 2012;307:173–81. Twenty-year longitudinal study; more harm may be associated with heavy, long-term use than occasional marijuana use..PubMedGoogle Scholar
  60. 60.
    Tashkin DP. Smoked marijuana as a cause of lung injury. Monaldi Arch Chest Dis. 2005;63:93–100.PubMedGoogle Scholar
  61. 61.
    Tashkin DP. Airway effects of marijuana, cocaine, and other inhaled illicit agents. Curr Opin Pulm Med. 2001;7:43–61.PubMedGoogle Scholar
  62. 62.
    Tashkin DP. Pulmonary complications of smoked substance abuse. West J Med. 1990;152:525–30.PubMedGoogle Scholar
  63. 63.
    Tetrault JM, Crothers K, Moore BA, et al. Effects of marijuana smoking on pulmonary function and respiratory complications: a systematic review. Arch Intern Med. 2007;167:221–8.PubMedGoogle Scholar
  64. 64.
    Polen MR, Sidney S, Tekawa IS, et al. Health care use by frequent marijuana smokers who do not smoke tobacco. West J Med. 1993;158:596–601.PubMedGoogle Scholar
  65. 65.
    Taylor DR, Poulton R, Moffitt TE, et al. The respiratory effects of cannabis dependence in young adults. Addiction. 2000;95:1669–77.PubMedGoogle Scholar
  66. 66.
    Taylor DR, Fergusson DM, Milne BJ, et al. A longitudinal study of the effects of tobacco and cannabis exposure on lung function in young adults. Addiction. 2002;97:1055–61.PubMedGoogle Scholar
  67. 67.
    Moore BA, Augustson EM, Moser RP, et al. Respiratory effects of marijuana and tobacco use in a U.S. sample. J Gen Intern Med. 2005;20:33–7.PubMedGoogle Scholar
  68. 68.
    Stokes JR, Hartel R, Ford LB, et al. Cannabis (hemp) positive skin tests and respiratory symptoms. Ann Allergy Asthma Immunol. 2000;85:238–40.PubMedGoogle Scholar
  69. 69.
    Sidney S. Cardiovascular consequences of marijuana use. J Clin Pharmacol. 2002;42(11 Suppl):64S–70S.PubMedGoogle Scholar
  70. 70.
    Aryana A, Williams MA. Marijuana as a trigger of cardiovascular events: speculation or scientific certainty? Int J Cardiol. 2007;118:141–4.PubMedGoogle Scholar
  71. 71.•
    Malinowska B, Baranowska-Kuczko M, Schlicker E. Triphasic blood pressure responses to cannabinoids: do we understand the mechanism? Br J Pharmacol. 2012;165:2073–88. Review of physiological cardiovascular effects related to cannabinoids..PubMedGoogle Scholar
  72. 72.
    Mittleman MA, Lewis RA, Maclure M, et al. Triggering myocardial infarction by marijuana. Circulation. 2001;103:2805–9.PubMedGoogle Scholar
  73. 73.•
    Frost L, Mostofsky E, Rosenbloom JI, et al. Marijuana use and long-term mortality among survivors of acute myocardial infarction. Am Heart J. 2013;165:170–5. Eighteen-year follow-up of cardiovascular mortality in marijuana users..PubMedGoogle Scholar
  74. 74.
    Rodondi N, Pletcher MJ, Liu K, et al. Marijuana use, diet, body mass index, and cardiovascular risk factors (from the CARDIA study). Am J Cardiol. 2006;98:478–84.PubMedGoogle Scholar
  75. 75.
    Mukamal KJ, Maclure M, Muller JE, et al. An exploratory prospective study of marijuana use and mortality following acute myocardial infarction. Am Heart J. 2008;155:465–70.PubMedGoogle Scholar
  76. 76.
    Peyrot I, Garsaud AM, Saint-Cyr I, et al. Cannabis arteritis: a new case report and a review of literature. J Eur Acad Dermatol Venereol. 2007;21:388–91.PubMedGoogle Scholar
  77. 77.
    Disdier P, Granel B, Serratrice J, et al. Cannabis arteritis revisited—ten new case reports. Angiology. 2001;52:1–5.PubMedGoogle Scholar
  78. 78.
    Block RI, O'Leary DS, Ehrhardt JC, et al. Effects of frequent marijuana use on brain tissue volume and composition. Neuroreport. 2000;11:491–6.PubMedGoogle Scholar
  79. 79.
    Matochik JA, Eldreth DA, Cadet JL, et al. Altered brain tissue composition in heavy marijuana users. Drug Alcohol Depend. 2005;77:23–30.PubMedGoogle Scholar
  80. 80.
    Medina KL, Schweinsburg AD, Cohen-Zion M, et al. Effects of alcohol and combined marijuana and alcohol use during adolescence on hippocampal volume and asymmetry. Neurotoxicol Teratol. 2007;29:141–52.PubMedGoogle Scholar
  81. 81.
    Jager G, van Hell HH, De Win MM, et al. Effects of frequent cannabis use on hippocampal activity during an associative memory task. Eur Neuropsychopharmacol. 2007;17:289–97.PubMedGoogle Scholar
  82. 82.
    Jacobsen LK, Mencl WE, Westerveld M, et al. Impact of cannabis use on brain function in adolescents. Ann N Y Acad Sci. 2004;1021:384–90.PubMedGoogle Scholar
  83. 83.
    Pillay SS, Rogowska J, Kanayama G, et al. Cannabis and motor function: fMRI changes following 28 days of discontinuation. Exp Clin Psychopharmacol. 2008;16:22–32.PubMedGoogle Scholar
  84. 84.
    Chang L, Yakupov R, Cloak C, et al. Marijuana use is associated with a reorganized visual-attention network and cerebellar hypoactivation. Brain. 2006;129:1096–112.PubMedGoogle Scholar
  85. 85.
    Kanayama G, Rogowska J, Pope HG, et al. Spatial working memory in heavy cannabis users: a functional magnetic resonance imaging study. Psychopharmacology (Berl). 2004;176:239–47.Google Scholar
  86. 86.
    Tapert SF, Schweinsburg AD, Drummond SP, et al. Functional MRI of inhibitory processing in abstinent adolescent marijuana users. Psychopharmacology (Berl). 2007;194:173–83.Google Scholar
  87. 87.
    Gonzalez R. Acute and non-acute effects of cannabis on brain functioning and neuropsychological performance. Neuropsychol Rev. 2007;17:347–61.PubMedGoogle Scholar
  88. 88.
    Pope Jr HG, Gruber AJ, Yurgelun-Todd D. The residual neuropsychological effects of cannabis: the current status of research. Drug Alcohol Depend. 1995;38:25–34.PubMedGoogle Scholar
  89. 89.
    Grant I, Gonzalez R, Carey CL, et al. Non-acute (residual) neurocognitive effects of cannabis use: a meta-analytic study. J Int Neuropsychol Soc. 2003;9:679–89.PubMedGoogle Scholar
  90. 90.
    Zachariah SB. Stroke after heavy marijuana smoking. Stroke. 1991;22:406–9.PubMedGoogle Scholar
  91. 91.
    Geller T, Loftis L, Brink DS. Cerebellar infarction in adolescent males associated with acute marijuana use. Pediatrics. 2004;113:e365–70.PubMedGoogle Scholar
  92. 92.
    Finsterer J, Christian P, Wolfgang K. Occipital stroke shortly after cannabis consumption. Clin Neurol Neurosurg. 2004;106:305–8.PubMedGoogle Scholar
  93. 93.
    Herning RI, Better WE, Tate K, et al. Marijuana abusers are at increased risk for stroke. Preliminary evidence from cerebrovascular perfusion data. Ann N Y Acad Sci. 2001;939:413–5.PubMedGoogle Scholar
  94. 94.
    Moussouttas M. Cannabis use and cerebrovascular disease. Neurologist. 2004;10:47–53.PubMedGoogle Scholar
  95. 95.
    Zaretsky A, Rector NA, Seeman MV, et al. Current cannabis use and tardive dyskinesia. Schizophr Res. 1993;11:3–8.PubMedGoogle Scholar
  96. 96.
    Stracciari A, Guarino M, Crespi C, et al. Transient amnesia triggered by acute marijuana intoxication. Eur J Neurol. 1999;6:521–3.PubMedGoogle Scholar
  97. 97.
    Bonkowsky JL, Sarco D, Pomeroy SL. Ataxia and shaking in a 2-year-old girl: acute marijuana intoxication presenting as seizure. Pediatr Emerg Care. 2005;21:527–8.PubMedGoogle Scholar
  98. 98.
    Lozsadi DA, Forster A, Fletcher NA. Cannabis-induced propriospinal myoclonus. Mov Disord. 2004;19:708–9.PubMedGoogle Scholar
  99. 99.
    Malec J, Harvey RF, Cayner JJ. Cannabis effect on spasticity in spinal cord injury. Arch Phys Med Rehabil. 1982;63:116–8.PubMedGoogle Scholar
  100. 100.
    Schwartz LS, Taylor JR. Attitudes of mental health professionals toward alcoholism recognition and treatment. Am J Drug Alcohol Abuse. 1989;15:321–37.PubMedGoogle Scholar
  101. 101.
    Wilson WH, Ellinwood EH, Mathew RJ, et al. Effects of marijuana on performance of a computerized cognitive-neuromotor test battery. Psychiatry Res. 1994;51:115–25.PubMedGoogle Scholar
  102. 102.
    Rizzo M, Lamers CT, Sauer CG, et al. Impaired perception of self-motion (heading) in abstinent ecstasy and marijuana users. Psychopharmacology (Berl). 2005;179:559–66.Google Scholar
  103. 103.
    Messinis L, Kyprianidou A, Malefaki S, et al. Neuropsychological deficits in long-term frequent cannabis users. Neurology. 2006;66:737–9.PubMedGoogle Scholar
  104. 104.
    Ramaekers JG, Kauert G, van Ruitenbeek P, et al. High-potency marijuana impairs executive function and inhibitory motor control. Neuropsychopharmacology. 2006;31:2296–303.PubMedGoogle Scholar
  105. 105.
    Urey JC. Some ocular manifestations of systemic drug abuse. J Am Optom Assoc. 1991;62:832–42.PubMedGoogle Scholar
  106. 106.
    Levi L, Miller NR. Visual illusions associated with previous drug abuse. J Clin Neuroophthalmol. 1990;10:103–10.PubMedGoogle Scholar
  107. 107.
    Parikh RS, Parikh SR. Alternative therapy in glaucoma management: is there any role? Indian J Ophthalmol. 2011;59:S158–60.PubMedGoogle Scholar
  108. 108.
    NEI. NEI statement: glaucoma and marijuana use. Available at nei.nih.gov/news/statements/marij.asp. Accessed June 2013.Google Scholar
  109. 109.
    Crowe AV, Howse M, Bell GM, et al. Substance abuse and the kidney. QJM. 2000;93:147–52.PubMedGoogle Scholar
  110. 110.
    Vupputuri S, Batuman V, Muntner P, et al. The risk for mild kidney function decline associated with illicit drug use among hypertensive men. Am J Kidney Dis. 2004;43:629–35.PubMedGoogle Scholar
  111. 111.
    Thompson ST. Preventable causes of male infertility. World J Urol. 1993;11:111–9.PubMedGoogle Scholar
  112. 112.
    Ramos JA, Bianco FJ. The role of cannabinoids in prostate cancer: basic science perspective and potential clinical applications. Indian J Urol. 2012;28:9–14.PubMedGoogle Scholar
  113. 113.
    Close CE, Roberts PL, Berger RE. Cigarettes, alcohol and marijuana are related to pyospermia in infertile men. J Urol. 1990;144:900–3.PubMedGoogle Scholar
  114. 114.
    Johnson SD, Phelps DL, Cottler LB. The association of sexual dysfunction and substance use among a community epidemiological sample. Arch Sex Behav. 2004;33:55–63.PubMedGoogle Scholar
  115. 115.•
    Simonetto DA, Oxentenko AS, Herman ML, et al. Cannabinoid hyperemesis: a case series of 98 patients. Mayo Clin Proc. 2012;87:114–9. Report of emerging under-reported consequence of marijuana use..PubMedGoogle Scholar
  116. 116.
    Buck GM, Sever LE, Batt RE, et al. Life-style factors and female infertility. Epidemiology. 1997;8:435–41.PubMedGoogle Scholar
  117. 117.
    Mueller BA, Daling JR, Weiss NS, et al. Recreational drug use and the risk of primary infertility. Epidemiology. 1990;1:195–200.PubMedGoogle Scholar
  118. 118.
    Crosby R, di Clemente RJ, Wingood GM, et al. Predictors of infection with Trichomonas vaginalis: a prospective study of low income African-American adolescent females. Sex Transm Infect. 2002;78:360–4.PubMedGoogle Scholar
  119. 119.
    Beigi RH, Meyn LA, Moore DM, et al. Vaginal yeast colonization in nonpregnant women: a longitudinal study. Obstet Gynecol. 2004;104:926–30.PubMedGoogle Scholar
  120. 120.
    Galiègue S, Mary S, Marchand J, et al. Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur J Biochem. 1995;232:54–61.PubMedGoogle Scholar
  121. 121.
    Ziring D, Wei B, Velazquez P, et al. Formation of B and T cell subsets require the cannabinoid receptor CB2. Immunogenetics. 2006;58:714–25.PubMedGoogle Scholar
  122. 122.
    Holly EA, Lele C, Bracci PM, et al. Case–control study of non-Hodgkin's lymphoma among women and heterosexual men in the San Francisco Bay Area, California. Am J Epidemiol. 1999;150:375–89.PubMedGoogle Scholar
  123. 123.
    Mohs ME, Watson RR, Leonard-Green T. Nutritional effects of marijuana, heroin, cocaine, and nicotine. J Am Diet Assoc. 1990;90:1261–7.PubMedGoogle Scholar
  124. 124.
    Matias I, Di MV. Endocannabinoids and the control of energy balance. Trends Endocrinol Metab. 2007;18:27–37.PubMedGoogle Scholar
  125. 125.
    Mokdad AH, Marks JS, Stroup DF, et al. Actual causes of death in the United States, 2000. JAMA. 2004;291:1238–45.PubMedGoogle Scholar
  126. 126.
    Bostwick JM. Blurred boundaries: the therapeutics and politics of medical marijuana. Mayo Clin Proc. 2012;87:172–86.PubMedGoogle Scholar
  127. 127.
    Harris, G. Researchers find study of medical marijuana discouraged. New York Times. 1-19-2010. Accessed on July 7 2013.Google Scholar

Copyright information

© Springer Science+Business Media New York (outside the USA) 2013

Authors and Affiliations

  • Adam J. Gordon
    • 1
    • 2
    • 4
  • James W. Conley
    • 1
    • 2
  • Joanne M. Gordon
    • 3
  1. 1.Center for Health Equity Research and Promotion (CHERP)VA Pittsburgh Healthcare SystemPittsburghUSA
  2. 2.Mental Illness Research, Education, and Clinical Center (MIRECC)VA Pittsburgh Healthcare SystemPittsburghUSA
  3. 3.Missouri State UniversitySpringfieldUSA
  4. 4.University of Pittsburgh School of MedicinePittsburghUSA

Personalised recommendations